Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SLNO
#1669
Soleno Therapeutics, Inc. Common Stock
39.0
7
+5.51%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+5.51%
Changement Mensuel
-9.20%
Evolution sur 6 mois
-42.34%
Changement Annuel
-13.27%
Clôture Précédente
37.0
3
Open
39.0
7
Bid
Ask
Low
39.0
7
High
39.0
7
Volume
143
Marchés
Actions des Marchés US
Soins de Santé
SLNO
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
Nouvelles
Soleno Therapeutics stock hits 52-week low at 36.01 USD
Soleno Therapeutics names Jennifer Fulk as CFO
Soleno Therapeutics earnings beat by $0.19, revenue topped estimates
Soleno Therapeutics faces earnings test as launch metrics scrutinized
Soleno Therapeutics stock hits 52-week low at 37.95 USD
Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround
FDA Accepts SMMT's Application Seeking Approval for NSCLC Drug
Soleno Therapeutics stock hits 52-week low at 39.42 USD
HCA Healthcare Q4 Earnings Beat Estimates on Strong Patient Volumes
Soleno Therapeutics stock price target raised to $120 from $110 at H.C. Wainwright
Soleno Therapeutics (SLNO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now